- Home
- LFVN vs ACHV Comparison
LFVN vs ACHV Comparison
Compare LFVN & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LFVN | ACHV |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.2M | 167.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | LFVN | ACHV |
|---|---|---|
| Price | $6.46 | $4.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $30.50 | $15.50 |
| AVG Volume (30 Days) | 148.9K | ★ 599.1K |
| Earning Date | 02-04-2026 | 11-06-2025 |
| Dividend Yield | ★ 2.77% | N/A |
| EPS Growth | ★ 143.91 | N/A |
| EPS | ★ 0.78 | N/A |
| Revenue | ★ $228,877,000.00 | N/A |
| Revenue This Year | $1.54 | N/A |
| Revenue Next Year | $7.00 | N/A |
| P/E Ratio | $8.34 | ★ N/A |
| Revenue Growth | ★ 16.77 | N/A |
| 52 Week Low | $5.98 | $1.84 |
| 52 Week High | $27.38 | $5.78 |
Technical Indicators
Market Signals| Indicator | LFVN | ACHV |
|---|---|---|
| Relative Strength Index (RSI) | 39.37 | 49.12 |
| Support Level | $6.34 | $4.57 |
| Resistance Level | $6.78 | $4.86 |
| Average True Range (ATR) | 0.31 | 0.31 |
| MACD | 0.07 | -0.02 |
| Stochastic Oscillator | 17.28 | 37.81 |
Price Performance
Historical ComparisonAbout LFVN Lifevantage Corporation (Delaware)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.